Is Afya (NASDAQ:AFYA) Still Undervalued Following Its Proposed Yduqs Merger?

Afya merger announcement sets the stage Afya (AFYA) has drawn fresh attention after announcing a proposed merger with Yduqs that would form a healthcare education group targeting about BRL 10b in revenue and BRL 2.2b in projected synergies. Recent trading shows momentum building in Afya, with a 30-day share price return of 16.08% and a 90-day gain of 6.27% around the merger headlines, while the 1-year total shareholder return of 7.12% contrasts with slightly weaker 3-year and 5-year...